Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jan 15;12(1):1-16.
eCollection 2022.

Artificial intelligence for early diagnosis of lung cancer through incidental nodule detection in low- and middle-income countries-acceleration during the COVID-19 pandemic but here to stay

Affiliations
Review

Artificial intelligence for early diagnosis of lung cancer through incidental nodule detection in low- and middle-income countries-acceleration during the COVID-19 pandemic but here to stay

Susana Goncalves et al. Am J Cancer Res. .

Abstract

Although the coronavirus disease of 2019 (COVID-19) pandemic had profound pernicious effects, it revealed deficiencies in health systems, particularly among low- and middle-income countries (LMICs). With increasing uncertainty in healthcare, existing unmet needs such as poor outcomes of lung cancer (LC) patients in LMICs, mainly due to late stages at diagnosis, have been challenging-necessitating a shift in focus for judicious health resource utilization. Leveraging artificial intelligence (AI) for screening large volumes of pulmonary images performed for noncancerous reasons, such as health checks, immigration, tuberculosis screening, or other lung conditions, including but not limited to COVID-19, can facilitate easy and early identification of incidental pulmonary nodules (IPNs), which otherwise could have been missed. AI can review every chest X-ray or computed tomography scan through a trained pair of eyes, thus strengthening the infrastructure and enhancing capabilities of manpower for interpreting images in LMICs for streamlining accurate and early identification of IPNs. AI can be a catalyst for driving LC screening with enhanced efficiency, particularly in primary care settings, for timely referral and adequate management of coincidental IPN. AI can facilitate shift in the stage of LC diagnosis for improving survival, thus fostering optimal health-resource utilization and sustainable healthcare systems resilient to crisis. This article highlights the challenges for organized LC screening in LMICs and describes unique opportunities for leveraging AI. We present pilot initiatives from Asia, Latin America, and Russia illustrating AI-supported IPN identification from routine imaging to facilitate early diagnosis of LC at a potentially curable stage.

Keywords: Artificial intelligence; incidental pulmonary nodules; low- and middle-income countries; lung cancer; screening.

PubMed Disclaimer

Conflict of interest statement

SG is Medical Director at AstraZeneca, LatAm Area; PC is Head of Oncology, International Medical at AstraZeneca and MB is Therapeutic Area Lead, Russia, at AstraZeneca.

Figures

Figure 1
Figure 1
Opportunities for incidental pulmonary nodule detection through artificial intelligence. CT: computed tomography; CXR: chest X-ray; COPD: chronic obstructive pulmonary disease.
Figure 2
Figure 2
A. Case study of artificial intelligence assisted incidental pulmonary nodule detection in Russia. AI: artificial intelligence; CT: computerized tomography; LC: lung cancer. B. Case study of artificial intelligence assisted incidental pulmonary nodule detection in Latin America. AI: artificial intelligence; API: application programming interface; CT: computerized tomography; LC: lung cancer; MDT: multidisciplinary team; PCP: primary care physician; RWE: real-world evidence. C. Case study of artificial intelligence assisted incidental pulmonary nodule detection in Asia. AI: artificial intelligence; CTS: cardiothoracic surgeons; GP: general practitioner; IPN: incidental pulmonary nodule; LC: lung cancer; RWE: real-world evidence.
Figure 3
Figure 3
SWOT analysis illustrating the strengths, weakness, opportunities and threats for AI in lung cancer detection. AI: artificial intelligence; S: strength; W: weakness; O: opportunity; T: threat; IPN: incidental pulmonary nodule; LMICs: low- and middle-income countries.
Figure 4
Figure 4
Roadmap for artificial intelligence assisted incidental pulmonary nodule detection in low- and middle-income countries. AI: artificial intelligence.

References

    1. Siegel RL, Miller KD, Jemal A. Siegel R, Naishadham D and Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70:7–30. - PubMed
    1. Chen TY, Fang YH, Chen HL, Chang CH, Huang H, Chen YS, Liao KM, Wu HY, Chang GC, Tsai YH, Wang CL, Chen YM, Huang MS, Su WC, Yang PC, Chen CJ, Hsiao CF, Hsiung CA. Impact of cooking oil fume exposure and fume extractor use on lung cancer risk in non-smoking Han Chinese women. Sci Rep. 2020;10:6774. - PMC - PubMed
    1. Corrales L, Rosell R, Cardona AF, Martín C, Zatarain-Barrón ZL, Arrieta O. Lung cancer in never smokers: the role of different risk factors other than tobacco smoking. Crit Rev Oncol Hematol. 2020;148:102895. - PubMed
    1. Arrieta O, Cardona AF, Martín C, Más-López L, Corrales-Rodríguez L, Bramuglia G, Castillo-Fernandez O, Meyerson M, Amieva-Rivera E, Campos-Parra AD, Carranza H, Gómez de la Torre JC, Powazniak Y, Aldaco-Sarvide F, Vargas C, Trigo M, Magallanes-Maciel M, Otero J, Sánchez-Reyes R, Cuello M. Updated frequency of EGFR and KRAS mutations in nonsmall-cell lung cancer in Latin America: the Latin-American consortium for the investigation of lung cancer (CLICaP) J Thorac Oncol. 2015;10:838–843. - PubMed
    1. Zhang YL, Yuan JQ, Wang KF, Fu XH, Han XR, Threapleton D, Yang ZY, Mao C, Tang JL. The prevalence of EGFR mutation in patients with non-small cell lung cancer: a systematic review and meta-analysis. Oncotarget. 2016;7:78985–78993. - PMC - PubMed

LinkOut - more resources